Summary
The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects. This FOA supports basic, translational, and clinical research projects that seek to identify the mechanisms of therapy-induced adverse sequelae, clinically characterize the adverse sequelae, or translate the mechanistic understanding into therapeutic approaches to prevent or minimize the development of long-term sequelae. Research projects should focus on mechanistic studies with translational endpoints and longitudinal clinical phenotyping to identify and validate clinical endpoints (biomarkers, imaging, patient-reported outcomes, or combined elements) for future use in clinical trials that will evaluate the efficacy of interventions designed to prevent or reduce specific adverse sequelae.
Eligibility
- County Governments
- For Profit Organizations Other Than Small Businesses
- Nonprofits Non Higher Education Without 501c3
- Special District Governments
- Private Institutions of Higher Education
- State Governments
- Independent School Districts
- City Or Township Governments
- Public and Indian Housing Authorities
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- Small Businesses
- Other
- Native American Tribal Governments Federally Recognized
- Public and State Institutions of Higher Education
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
Funding categories
- Health
- Education
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record